This financial success underscores radioligand therapeutics' immense commercial and therapeutic potential, signalling their emergence as a pillar of modern oncology. With proof-of-concept ...

These patterns not only inflate expenditures but also disrupt the carefully calibrated treatment schedules that characterize modern oncology practice. Delays in chemotherapy or radiation—whether ...